When Gilead acquired Forty Seven Inc. in 2020, most observers called it quick. Those who tracked macrophage checkpoint research knew it was inevitable. That’s the power of strategic intelligence—not reacting to news, but foreseeing inevitabilities. At Octavus Consulting, we help clients move from rumor-driven scouting to pattern-based acquisition strategy. In 2025’s market—where capital discipline and […]

An Overview With high-paced technological advancement and incessant innovations, the healthcare sectors are transcending beyond excellence. The advent of the COVID-19 pandemic has reshaped the way clinical studies function, by availing the use of telemedicine and wearable devices. Often referred to as “direct-to-participant trials” or “virtual studies”, decentralized clinical trials mitigate the dependence on conventional-style […]